Quarterly report [Sections 13 or 15(d)]

Consolidated Statement of Stockholders' Equity

v3.25.3
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2023   81,818      
Balance at beginning of period at Dec. 31, 2023 $ 686,265 $ 8 $ 808,575 $ (3,791) $ (118,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,249      
Common stock issued pursuant to equity awards, net 8,777   8,777    
Stock-based compensation 17,032   17,032    
Other comprehensive income (loss) (1,782)     (1,782)  
Net loss (72,309)       (72,309)
Balance at end of period (in shares) at Mar. 31, 2024   83,067      
Balance at end of period at Mar. 31, 2024 637,983 $ 8 834,384 (5,573) (190,836)
Balance at beginning of period (in shares) at Dec. 31, 2023   81,818      
Balance at beginning of period at Dec. 31, 2023 686,265 $ 8 808,575 (3,791) (118,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (187,360)        
Balance at end of period (in shares) at Sep. 30, 2024   84,362      
Balance at end of period at Sep. 30, 2024 556,872 $ 8 866,603 (3,852) (305,887)
Balance at beginning of period (in shares) at Mar. 31, 2024   83,067      
Balance at beginning of period at Mar. 31, 2024 637,983 $ 8 834,384 (5,573) (190,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   655      
Common stock issued pursuant to equity awards, net (545)   (545)    
Employee stock purchase plan (in shares)   176      
Employee stock purchase plan 2,682   2,682    
Stock-based compensation 17,344   17,344    
Other comprehensive income (loss) (943)     (943)  
Net loss (39,266)       (39,266)
Balance at end of period (in shares) at Jun. 30, 2024   83,898      
Balance at end of period at Jun. 30, 2024 617,255 $ 8 853,865 (6,516) (230,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   464      
Common stock issued pursuant to equity awards, net (56)   (56)    
Stock-based compensation 12,794   12,794    
Other comprehensive income (loss) 2,664     2,664  
Net loss (75,785)       (75,785)
Balance at end of period (in shares) at Sep. 30, 2024   84,362      
Balance at end of period at Sep. 30, 2024 $ 556,872 $ 8 866,603 (3,852) (305,887)
Balance at beginning of period (in shares) at Dec. 31, 2024 84,613 84,613      
Balance at beginning of period at Dec. 31, 2024 $ 516,283 $ 8 886,823 (6,823) (363,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,761      
Common stock issued pursuant to equity awards, net 2,877 $ 1 2,876    
Stock-based compensation 22,871   22,871    
Other comprehensive income (loss) 857     857  
Net loss (49,713)       (49,713)
Balance at end of period (in shares) at Mar. 31, 2025   86,374      
Balance at end of period at Mar. 31, 2025 $ 493,175 $ 9 912,570 (5,966) (413,438)
Balance at beginning of period (in shares) at Dec. 31, 2024 84,613 84,613      
Balance at beginning of period at Dec. 31, 2024 $ 516,283 $ 8 886,823 (6,823) (363,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (121,784)        
Balance at end of period (in shares) at Sep. 30, 2025 87,373 87,373      
Balance at end of period at Sep. 30, 2025 $ 464,727 $ 9 950,067 160 (485,509)
Balance at beginning of period (in shares) at Mar. 31, 2025   86,374      
Balance at beginning of period at Mar. 31, 2025 493,175 $ 9 912,570 (5,966) (413,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   331      
Employee stock purchase plan (in shares)   202      
Employee stock purchase plan 2,178   2,178    
Stock-based compensation 13,264   13,264    
Other comprehensive income (loss) 6,300     6,300  
Net loss (26,586)       (26,586)
Balance at end of period (in shares) at Jun. 30, 2025   86,907      
Balance at end of period at Jun. 30, 2025 488,331 $ 9 928,012 334 (440,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   466      
Common stock issued pursuant to equity awards, net 615   615    
Stock-based compensation 21,440   21,440    
Other comprehensive income (loss) (174)     (174)  
Net loss $ (45,485)       (45,485)
Balance at end of period (in shares) at Sep. 30, 2025 87,373 87,373      
Balance at end of period at Sep. 30, 2025 $ 464,727 $ 9 $ 950,067 $ 160 $ (485,509)